Latest California Healthline Stories
KHN’s ‘What the Health?’: Delta Blues
Covid is back with a vengeance, with some people clamoring for booster shots while others harden their resistance to getting vaccinated at all. Meanwhile, the Food and Drug Administration is pushing hard on drugmaker Pfizer’s request to upgrade the emergency authorization for its vaccine and give it final approval. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite health policy stories of the week they think you should read, too.
2+2=? Senate Uses Murky Math as It Shelves Drug Pricing Rule to Fund Infrastructure
The Medicare rule, designed by the Trump administration to take money away from drug industry brokers and provide refunds to patients, has not been implemented. But budget analysts say if it were, it would cost the government money. So senators are pushing the rule aside and claiming to save billions of dollars, which they want to use instead on new projects.
Providence-KP Team Up to Attract Patients in California’s Growing High Desert Region
Providence, the country’s 10th-biggest hospital chain, says it’s too expensive to upgrade an older hospital, so it will join forces with giant Kaiser Permanente to build a new one.
New Moms Latched On to Remote Breastfeeding Help. Will Demand Wane as Pandemic Fades?
The pandemic forced new parents to find help with breastfeeding online. Now, some offerings are remaining virtual to help expand access to lactation support.
At Urgent Care, He Got 5 Stitches and a Big Surprise: A Plastic Surgeon’s Bill for $1,040
The Biden administration is weighing how to treat urgent care clinics as part of broad regulations banning surprise, out-of-network medical bills. At the heart of the matter: What counts as an emergency?
Claims That CDC’s PCR Test Can’t Tell Covid From Flu Are Wrong
Posts circulating on Facebook and Instagram incorrectly claim that the Centers for Disease Control and Prevention is withdrawing its covid test because it can’t differentiate between that virus and flu viruses. These statements could be an attempt to blur the high cumulative numbers of covid cases.
Facing Recall, Newsom Draws Support from Health Care Allies
California Gov. Gavin Newsom faces a recall election in September, fueled in part by anger over his pandemic policies. The health care industry has ponied up more than $4.8 million so far to defend the first-term Democrat.
Bus Stop by Bus Stop, Denver-Area Officials Microtarget Vaccine Hesitancy
Using detailed maps that show vaccination rates down to the ZIP code or census tract level, health departments highlight areas of greater Denver where vaccinations lag behind state or county averages, then partner with community organizations to overcome barriers. Can this be a model for President Joe Biden’s “neighborhood by neighborhood” approach?
KHN’s ‘What the Health?’: Hot Covid Summer
The summer that promised to let Americans resume a relatively normal life is turning into another summer of anxiety and face masks, as the delta variant drives covid caseloads up in all 50 states. Meanwhile, the Americans with Disabilities Act turns 35, and the Missouri Supreme Court orders the state to expand Medicaid after all. Mary Ellen McIntire of CQ Roll Call, Anna Edney of Bloomberg News and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews KHN’s Samantha Young, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about an Olympic-level athlete with an Olympic-size medical bill.
Pfizer Court Fight Could Legalize Medicare Copays and Unleash ‘Gold Rush’ in Sales
Pharmaceutical companies routinely cover the cost of patient copays for expensive drugs under private insurance. A federal judge could make the practice legal for millions on Medicare as well.